Results 121 to 130 of about 313,394 (308)
Medicine ScienceOsteoporosis is a prevalent skeletal disorder characterized by decreased bone mineral density and an increased risk of fractures, particularly in postmenopausal women.
Kenan Bentli, Can Demirel
doaj +1 more source
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
Experimental and Molecular Medicine, 2018 Osteoporosis: protein trigger for postmenopausal bone loss identified A protein that helps trigger bone loss in postmenopausal osteoporosis could be a potential therapeutic target.
Joo-Hee Choi +6 more
doaj +1 more source
The Effect of Continous or Intermittent Calcitonin in the Treatment of Postmenopausal Osteoporosis
, 2002 The aim of this study was to compare the efficacy of continuous and intermittent salmon calcitonin in the treatment of postmenopausal osteoporosis. Sixty-eight women with postmenopausal osteoporosis were randomized to 2 treatment groups. The first group
F. Taşçıoğlu, C. Öner, O. Armağan
core
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
Clinical Endocrinology, EarlyView.ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley +1 more source
, 2006 Aim: The aim of this study was to compare the efficacy of risendronate and raloxifene treatments on bone mineral density (BMD) and biochemical markers of bone turnover in postmenopausal osteoporosis.
Cengiz Öner +4 more
core
Lifestyle Management in Menopause: A Systematic Review of Women With Premature Ovarian Insufficiency
Clinical Endocrinology, EarlyView.ABSTRACT Objective Premature ovarian insufficiency (POI), the loss of ovarian function before age 40, increases the risk of cardiovascular disease, low bone mineral density, dementia and psychological distress. Lifestyle interventions reduce chronic disease risk in other populations and, with hormone therapy, may improve health outcomes in POI.
Ladan Yeganeh +4 more
wiley +1 more source
International Journal of Women's HealthSongfeng Zhao,1,2 Xin Pan1,2 1Department of Endocrinology, The First People’s Hospital of Xiaoshan District, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Endocrinology, Xiaoshan Affiliated Hospital of Wenzhou Medical University ...
Zhao S, Pan X
doaj
A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis [PDF]
Osteoporosis is a major cause of morbidity, mortality and resource cost amongst the elderly population. Hip fracture is the most serious of the osteoporotic fractures, with approximately 10-20% of patients dying within six months of sustaining a fracture.
Bernie O'Brien +3 more
core
Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions
, 2001 Assessing the cost-effectiveness of long-term treatment for osteoporosis requires use of mathematical models to estimate health effects and costs for competing interventions.
Adachi, J D, +5 more
core +1 more source
Cell Proliferation, EarlyView.In this study, OP‐BMSCs were successfully isolated from OVX osteoporotic rats. Mechanistic investigations revealed that the RNA‐binding protein YTHDF3 significantly upregulates Tbx19 expression by enhancing the stability of Tbx19 mRNA. Elevated Tbx19 levels, in turn, activate key osteogenic molecules, effectively promoting the differentiation of OP ...
Qianke Tao +9 more
wiley +1 more source